Loading company…
MingCeler develops genetically engineered animal models and research services for life sciences.
Founded in 2022 and based in Guangzhou, China, MingCeler develops genetically engineered animal models and related research services for biomedical, pharmaceutical and life sciences applications. Its TurboMice™ technology is used to create gene-edited mouse models, including homozygous models. The company is a joint incubator of Guangzhou Laboratory and Bio Island Laboratory and was founded by Guangming Wu. It closed a Series A round in July 2026 to expand laboratory capacity, build a stem cell seed bank and establish an overseas sales team.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in